Occlutech Holding AG
SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / December 21, 2021 / Occlutech Holding AG
Occlutech Holding AG ("Occlutech" or the "Company"), a leading specialist provider of minimally invasive structural heart disease devices, addressing congenital heart defects, stroke prevention and heart failure, has successfully completed a private placement of shares (the "Private Placement") of 450 MSEK before transaction costs, to the Fourth Swedish National Pension Fund, Carnegie Private Banking and certain other investors. The purpose of the issue is to support Occlutech's significant opportunities in the U.S. market, continue to facilitate Occlutech's growth, as well as to repay maturing loans.
Occlutech has completed a Private Placement corresponding to SEK 450 million before transaction costs to finance the Company's growth ambition. The Private Placement attracted a lot of interest and was led by the Fourth Swedish National Pension Fund and Carnegie Private Banking.
Occlutech sells its products in over 85 countries, whereby the European market is dominant with a strong market share. The Company has a clear growth strategy, both in existing markets as well as through further global expansion. In particular, the U.S. market is expected to have significant growth opportunities for Occlutech's products and is therefore considered a future key market.
Earlier this year Occlutech set up a subsidiary in the U.S., focusing on clinical, regulatory, logistics, and supporting distribution. The Company also received granted conditional approval from the U.S. Food and Drug Administration (FDA) for IDE applications to conduct a pivotal Patent Foramen Ovale (PFO) study for Occlutech's PFO Occluder and a pivotal study for Occlutech's Atrial Flow Regulator (AFR) device for heart failure. The Company anticipates receiving an FDA market approval for the U.S. in 2026.
"Occlutech's sales continue to progress with good momentum, confirming the quality and competitiveness of the company's products. The U.S. market represents a significant growth potential for Occlutech and the financial strength that comes from the Private Placement allows Occlutech to continue with clinical trials for regulatory approvals in the U.S. for both the AFR device for heart failure and the PFO Occluder for stroke prevention", says Sabine Bois, CEO of Occlutech.
"Occlutech's Board welcomes the Fourth Swedish National Pension Fund and Carnegie Private Banking, together with other investors as new shareholders in Occlutech. The successful Private Placement of SEK 450 million, before transaction costs, confirms the confidence in Occlutech's products and market potential, with the aim of generating long-term value creation for both society and shareholders", says Marianne Dicander Alexandersson, Chairperson of Occlutech.
According to a market study, by the consulting firm Roland Berger, the developing market for interatrial shunt devices, such as Occlutech's Atrial Flow Regulator for heart failure, has an estimated market potential of about €3.9 billion in 2021 in the U.S. and EU5 (France, Germany, Italy, Spain, United Kingdom). The study also indicates that the global addressable market within structural heart disease devices is estimated at approximately €350-400 million in 2021 and is expected to grow around 10 percent annually in the next five years. Births and increased treatment adoption drive structural heart volumes while aging populations as well as lifestyle diseases, such as diabetes and overweight, cause heart failure volumes to increase.
Advisers
Carnegie Investment Bank AB (publ) acted as sole financial adviser to Occlutech. Baker McKenzie acted as the legal adviser to Occlutech as to Swedish and Swiss law.
Contacts
Sabine Bois
CEO
E-mail: sabine.bois@occlutech.com
Lars Wadell
CFO
Email: lars.wadell@occlutech.com
Phone: +46 763 20 04 34
Image Attachments
Sabine Bois CEO
Marianne Dicander Alexandersson Chairperson
Attachments
Occlutech has successfully completed a Private Placement of 450 MSEK to support growth
SOURCE: Occlutech Holding AG
View source version on accesswire.com:
https://www.accesswire.com/678813/Occlutech-has-Successfully-Completed-a-Private-Placement-of-450-MSEK-to-Support-growth
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Latest GA Autonomous Jet Demo Features Live Air-to-Air Engagement Capability17.7.2025 18:10:00 CEST | Press release
Autonomous Tasking With TacACE and Optix.C2 Showcase Maturity and Operational Readiness SAN DIEGO, CALIFORNIA / ACCESS Newswire / July 17, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI) and General Atomics Integrated Intelligence, Inc. (GA-Intelligence) successfully completed a groundbreaking demonstration on July 8, integrating technologies across multiple affiliates to showcase long-range kill chain effects, including an autonomous air-to-air engagement. The flight integrated local and global sensor fusion to deliver real-time situational awareness and autonomous tasking to an airborne MQ-20 Avenger® through the Tactical Autonomy Core Ecosystem (TacACE) to close the kill chain and showcase the system's maturity and operational readiness for the warfighter. The event featured the integration of a Collaborative Combat Aircraft (CCA), a fully compliant government-owned autonomy implementation, and beyond-line-of-sight (BLOS) Command and Control (C2). The MQ-20 unmanned jet,
Belgian Aircrew Completes MQ-9B Training17.7.2025 18:05:00 CEST | Press release
GA-ASI's MQ-9B SkyGuardian® Training Was Conducted at Multiple Sites, Including Flight Test & Training Center and Desert Horizon SAN DIEGO, CALIFORNIA / ACCESS Newswire / July 17, 2025 / The first Belgian aircrew has completed training to operate the world's leading remotely piloted aircraft (RPA): the MQ-9B SkyGuardian®. General Atomics Aeronautical Systems, Inc. (GA-ASI), designer and developer of the MQ-9B, provided the extensive aircrew training that culminated at GA-ASI's Desert Horizon test facility in El Mirage, California, following stops in Belgium and GA-ASI's Flight Test & Training Center in North Dakota. "Providing all-encompassing training for the aircrews of our customers goes hand in hand with delivering the world's most capable RPA," said GA-ASI President David R. Alexander. "Completing this training ensures that Belgium is ready and able to operate their MQ-9Bs and maximize the benefits that come from long-range, high-endurance RPA." The scope of the training is focuse
A New Transatlantic Partnership for European CCA17.7.2025 18:00:00 CEST | Press release
General Atomics announces plans for rapid international uncrewed fighter development FAIRFORD, UK / ACCESS Newswire / July 17, 2025 / General Atomics is taking a bold step toward rapidly delivering a European Collaborative Combat Aircraft (CCA) - based on a mature U.S. platform, assembled in Europe, with European mission systems - by aligning its independent U.S. and German aerospace affiliates under a teamed operation.YFQ-42A The new aircraft is derived from the U.S. Air Force's YFQ-42A prototype, currently in ground testing and scheduled for first flight later this summer, designed and built by General Atomics Aeronautical Systems, Inc. (GA-ASI) in San Diego, Calif. European mission system customization and manufacturing in Europe will be supported by General Atomics' German aerospace affiliate, General Atomics Aerotec Systems GmbH (GA-ATS), headquartered in Oberpfaffenhofen, near Munich. Leveraging the prior investments of these established aerospace companies on both sides of the A
The Digital Banker17.7.2025 15:30:00 CEST | Press release
In this July 2025 article for the Fast Company Executive Board, Avtar Sehmbi of the Forbes Technology Council explains why Chief Technology Officers (CTOs) are increasingly positioned to lead the future of banking. LONDON, GB / ACCESS Newswire / July 17, 2025 / Artificial intelligence (AI) and other emerging technologies are reshaping banking by automating tasks, enhancing data analysis, and enabling personalized services. These tools improve risk management, streamline operations, and boost profitability. Institutions like JPMorgan Chase and Bank of America are already leveraging AI for fraud detection, customer service, and advanced analytics. Meanwhile, AI-powered hedge funds and neobanks use technology to deliver tailored experiences and outperform their peers.Avtar Sehmbi The Digital Banker Fast Company Avtar Sehmbi the Digital banker This shift isn't theoretical; it's already well underway. Digital systems are fully embedded into the everyday operations of financial institutions,
Global Sports Brand U.S. Polo Assn. Launches First Retail Store in Berlin, Germany16.7.2025 16:37:00 CEST | Press release
Brand Targets Aggressive Retail, Wholesale and Ecommerce Expansion WEST PALM BEACH, FL AND BERLIN, GERMANY / ACCESS Newswire / July 16, 2025 / U.S. Polo Assn., the official brand of the United States Polo Association (USPA), is proud to announce its first retail store in Germany alongside its brand partners Incom S.p.a. and Modevertrieb Sarnacchiaro GmbH (MVS). The location of the first U.S. Polo Assn. store in the heart of Berlin is at the premier Alexa Mall at Alexanderplatz and marks the beginning of a strategic retail rollout across the country, which solidifies the multi-billion-dollar brand's global presence in Germany. The new Berlin store is offering a curated selection of men's, women's, undergarments, and beachwear collections - a perfect mix of sports heritage and contemporary spirit.U.S. Polo Assn. Executives J. Michael Prince, Antonio Sarnacchiaro, and Lorenzo Nencini with U.S. Polo Assn. Models U.S. Polo Assn. is a symbol of style that blends sports inspiration and authen
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom